Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Richard Houk (NPI 1497783757)

Field	Value
Entity Type	Individual
Organization	Richard Houk
Address	9101 Kanis Rd Ste 200
City	Little Rock
State	AR
ZIP	72205
Taxonomy	Rheumatology Physician
NPI Enumerated	June 28, 2006

Payer Source	Total Paid
Medicare	$4.9M
Medicaid	$0

Key Findings

RICHARD HOUK is a rheumatology physician in LITTLE ROCK with an NPI enumerated 2006-06-28 (~20 years ago) and $4.9M in lifetime Medicare revenue; there is no Medicaid billing on file, so the practice effectively operates as a single-payer (Medicare) revenue model. This payer concentration means Medicare reimbursement policies and utilization trends will drive most financial performance for this provider.

Revenue is highly concentrated: the precomputed top-3 Medicare codes (J0129, J9312, J0717) account for 78.2% of the provider's total Medicare revenue. Individually those codes are J0129 $2.6M (53.3%), J9312 $621.4K (12.5%), and J0717 $614.4K (12.4%), indicating the practice’s income is dominated by a small set of biologic drug administrations.

The code mix is characteristic of an infusion/injection-centered rheumatology practice: high-volume biologic drug administrations such as J0129 (abatacept), J9312 (rituximab), J0717 (certolizumab pegol), plus other IV biologics J1602 (golimumab) and J1745 (infliximab). Presence of high-volume drug codes alongside administration/chemotherapy codes (96413, 96401) and joint procedures (20611, J7328) indicates the provider delivers both office-based infusions and in-clinic procedural care rather than solely outpatient E/M visits.

Operational scale appears substantial: J0717 shows 153.6K claims and J0129 shows 77.8K claims, and the administration codes 96413 (1.7K claims, $151K revenue) and 96401 (1K claims, $53.1K revenue) are each described as extreme outliers or notably above peers. Those volumes and outlier ranks support an inference of an on-site infusion suite or a high-throughput biologics administration program capable of managing frequent, supervised injectable therapies.

Competitive standing is uneven across codes: the provider ranks #1 of 1221 for J0129 at the 100th percentile (described as an extreme outlier), indicating national-level dominance in abatacept administration, while J9312 ranks #8 of 317 (98th percentile; notably above typical national volume) showing strong national presence for rituximab. By contrast J0717 ranks #58 of 848 (93th percentile; typical, unremarkable volume), so not all high-revenue drugs show the same degree of outlier activity.

The practice also reports substantial office evaluation-and-management activity alongside infusion services: 99214 has 1.6K claims and $138.4K revenue and ranks #2929 of 479517 (99th percentile; extreme outlier), suggesting a high volume of established-patient visits supporting the infusion/therapy workflow. Ancillary procedural codes such as 20611 (384 claims, $34.2K) and 76942 (23 claims, $897) indicate integrated procedural capabilities (arthrocentesis with ultrasound guidance and diagnostic imaging) consistent with comprehensive rheumatology care.

From a revenue-risk and contracting perspective, the lack of Medicaid billing and the fact that 78.2% of Medicare revenue is tied to three drug administration codes create a concentration exposure: changes to reimbursement, coverage, or utilization for J0129, J9312, or J0717 would materially affect total revenue. Analysts should prioritize review of utilization trends, payer edits, and contract terms for those specific biologic administration codes when assessing financial vulnerability or negotiating network arrangements.

Several codes are flagged as statistical outliers relative to national peers and warrant attention in utilization or network reviews: J0129 is labeled an "extreme outlier" at the 100th percentile, and chemotherapy/administration codes 96413 (rank #7 of 7514, 100th percentile; extreme outlier) and 96401 (rank #61 of 3868, 98th percentile; extreme outlier) are also unusually high. These outlier labels, combined with high absolute claim counts for specific biologics, should be considered signals of atypical scale in drug administration when benchmarking against other rheumatology providers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

26 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	77,800	$30	$2.6M
J9312	Injection, rituximab, 10 mg	9,710	$60	$621.4K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	153,600	$1	$614.4K
J1602	Injection, golimumab, 1 mg, for intravenous use	29,950	$10	$329.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	7,100	$30	$184.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,680	$90	$151K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,610	$90	$138.4K
J0897	Injection, denosumab, 1 mg	4,020	$20	$72.4K
J7328	Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg	64,010	$1	$64K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,040	$50	$53.1K

Showing 1–10 of 26

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Richard Houk — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

26 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	1	20	8,960	$30	$532.4K
J9312	1	10	6,500	$60	$393.8K
J0717	1	10	66,400	$1	$278.1K
J1602	4	10	15,300	$10	$185.4K
J1745	1	10	3,150	$30	$102.3K
J0897	62	160	2,580	$20	$89.7K
96413	1	80	380	$90	$36.6K
J7328	1	10	64,010	$1	$34.9K
J3304	7	20	1,440	$10	$23.8K
99214	48	4,300	130	$70	$18.8K

Showing 1–10 of 26

Related Providers

Other providers that share a Tax Identification Number (TIN) with Richard Houk, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tamer Alsebai	AR	Rheumatology Physician	$2.2M	$0
Cummins Lue	AR	Rheumatology Physician	$717.3K	$0
Allen Redding	AR	Endocrinology, Diabetes & Metabolism Physician	$708.8K	$0
Zulekha Hamid	AR	Endocrinology, Diabetes & Metabolism Physician	$514.5K	$0
Samer Homsi	AR	Pulmonary Disease Physician	$442K	$0
Raymond Edwards	AR	Internal Medicine Physician	$402.7K	$0
Alicia Bell	AR	Family Nurse Practitioner	$386.4K	$0
Heath Showalter	AR	Internal Medicine Physician	$369.2K	$0
Mark Dyer	AR	Internal Medicine Physician	$294.9K	$0
Renee Peterkin-mccalman	AR	Rheumatology Physician	$285.7K	$0

Nearby Providers

Other providers in the same ZIP code as Richard Houk, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Arkansas For Medical Sciences	AR	General Acute Care Hospital	$0	$87.2M
University Of Arkansas For Medical Sciences	AR	Internal Medicine Physician	$0	$28.6M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Arkansas Department Of Health Immunizations	AR	Public Health or Welfare Agency	$0	$19.3M
Baptist Health	AR	General Acute Care Hospital	$0	$16.4M
Arkansas Department Of Health Family Planning Clinic	AR	Public Health or Welfare Agency	$0	$15.6M
Pediatrix Medical Group Of Arkansas PA	AR	Neonatal-Perinatal Medicine Physician	$0	$14.6M
Chenal Family Therapy, Plc	AR	Mental Health Counselor	$0	$12.2M
Francis A. Allen School For Exceptional Children, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.9M
Central Arkansas Radiation Therapy Institute Inc	AR	Hematology & Oncology Physician	$0	$11M

Richard Houk — Billing Profile & Reimbursement Data

Sign up for Richard Houk — Billing Profile & Reimbursement Data policy alerts

Richard Houk — Billing Profile & Reimbursement Data

Sign up for Richard Houk — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References